Ying X - Search Results

1

Activation of COL11A1 by PRRX1 promotes tumor progression and radioresistance in ovarian cancer.

Zhu M, Ye C, Wang J, Yang G, Ying X. Zhu M, et al. Among authors: ying x. Int J Radiat Biol. 2021;97(7):958-967. doi: 10.1080/09553002.2021.1928780. Epub 2021 May 25. Int J Radiat Biol. 2021. PMID: 33970764

2

MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.

Ying X, Wei K, Lin Z, Cui Y, Ding J, Chen Y, Xu B. Ying X, et al. Cell Physiol Biochem. 2016;39(2):501-10. doi: 10.1159/000445642. Epub 2016 Jul 7. Cell Physiol Biochem. 2016. PMID: 27383536 Free article.

3

Wilms' tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling.

Han Y, Song C, Zhang T, Zhou Q, Zhang X, Wang J, Xu B, Zhang X, Liu X, Ying X. Han Y, et al. Among authors: ying x. Cell Cycle. 2020 Oct;19(20):2662-2675. doi: 10.1080/15384101.2020.1817666. Epub 2020 Sep 7. Cell Cycle. 2020. PMID: 32892698 Free PMC article.

4

Perfluorooctanoic acid stimulates ovarian cancer cell migration, invasion via ERK/NF-κB/MMP-2/-9 pathway.

Li X, Bao C, Ma Z, Xu B, Ying X, Liu X, Zhang X. Li X, et al. Among authors: ying x. Toxicol Lett. 2018 Sep 15;294:44-50. doi: 10.1016/j.toxlet.2018.05.009. Epub 2018 May 9. Toxicol Lett. 2018. PMID: 29753068

5

Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11.

Li Y, Kong C, Wu C, Wang Y, Xu B, Liang S, Ying X. Li Y, et al. Among authors: ying x. Biosci Rep. 2019 Jul 25;39(7):BSR20181794. doi: 10.1042/BSR20181794. Print 2019 Jul 31. Biosci Rep. 2019. PMID: 31123170 Free PMC article.

6

Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP.

Liu Y, Xu B, Liu M, Qiao H, Zhang S, Qiu J, Ying X. Liu Y, et al. Among authors: ying x. J Cancer. 2021 Jan 16;12(6):1660-1668. doi: 10.7150/jca.47344. eCollection 2021. J Cancer. 2021. PMID: 33613753 Free PMC article.

7

Autotransplantation of the ovarian cortex after in-vitro activation for infertility treatment: a shortened procedure.

Zhai J, Zhang J, Zhang L, Liu X, Deng W, Wang H, Zhang Z, Liu W, Chen B, Wu C, Long H, Xu B, Ying X, Zou H, He J, Li P, Hu T, Xiang W, Li J. Zhai J, et al. Among authors: ying x. Hum Reprod. 2021 Jul 19;36(8):2134-2147. doi: 10.1093/humrep/deab143. Hum Reprod. 2021. PMID: 34268564

8

BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively.

Li CR, Xie SY, Zhang SP, Yang YJ, Yang LL, Cao Y, Wang LL, Zhu FY, Wang RL, Yang ZX, Cui CC, Li YR, Xu JN, Yue F, Tian PZ, Wang Q, Yao HJ, Guan YC, Zhang SD, Ying XY, Zhang D, Zhang CL. Li CR, et al. Clin Transl Med. 2024 Oct;14(10):e70051. doi: 10.1002/ctm2.70051. Clin Transl Med. 2024. PMID: 39412213 Free PMC article. No abstract available.

9

Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK/mTOR signaling.

Ma Z, Liu X, Li F, Wang Y, Xu Y, Zhang M, Zhang X, Ying X, Zhang X. Ma Z, et al. Among authors: ying x. Oncotarget. 2016 Oct 11;7(41):66558-66568. doi: 10.18632/oncotarget.11684. Oncotarget. 2016. PMID: 27589685 Free PMC article.

10

PNMA5 knockdown suppresses the proliferation, invasion, and metastasis of epithelial ovarian cancer cells.

Qiao H, Liu J, Yang Z, Gao L, Zhang X, Lu G, Liu Y, Liu M, Ying X, Zhang D. Qiao H, et al. Among authors: ying x. Transl Cancer Res. 2020 May;9(5):3691-3702. doi: 10.21037/tcr-20-2013. Transl Cancer Res. 2020. PMID: 35117731 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,340 results

Search Page

Filters